Glenmark Pharmaceuticals Limited, a active public limited company, was established on 18 November 1977 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24299MH1977PLC019982. Registered under ROC Roc Mumbai. it is listed on BSE: 532296 and NSE: GLENMARK. It has an authorized capital of ₹277.00 Cr and a paid-up capital of ₹28.22 Cr.
Formerly known as Glenmark Pharmaceuticals Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹9,059.14 Cr and a net worth of ₹22,970.62 Cr. Employing 13,458 professional, Its leadership includes Glenn Mario Saldanha (Managing Director), Dipankar Bhattacharjee (Director), Blanche Saldanha Elizabeth (Director). Past directors included Marshall Joseph Mendonza, Mahadevan Gopal Krishnan, Natvarlal Bhimbhai Desai. It holds ₹890.00 Cr open charges and ₹1,040.00 Cr settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-2Mahalaxmi Chambers22 Bhulabhai Desai Road Mahalaxmi, Mumbai, Maharashtra, 400026.
L24299MH1977PLC019982
019982
18 November 1977
₹277.00 Cr
₹28.22 Cr
Roc Mumbai
Listed (BSE: 532296, NSE: GLENMARK)
Active
Explore comprehensive insights into Glenmark Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Glenn Mario Saldanha | Managing Director | 12 Oct 1998 | Current |
| Dipankar Bhattacharjee | Director | 14 Aug 2020 | Current |
| Blanche Saldanha Elizabeth | Director | 14 Aug 2009 | Current |
| Sona Saira Ramasastry | Director | 01 Apr 2019 | Current |
| Anurag Mantri | Cfo | 27 May 2025 | Current |
| Pradeep Kumar Sinha | Director | 14 Feb 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | 07 May 2013 | Past |
| Pramod Abcsdd | Director | 29 Jan 2010 | Past |
| Pramod Abcsdd | Director | 01 Jun 2015 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2020 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2009 | Past |
| Pramod Abcsdd | Whole-Time Director | 10 May 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Glenmark Pharmaceuticals Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 1.6% decrease. The company also saw a substantial improvement in profitability, with a 327.48% increase in profit. The company's net worth Soared by an impressive increase of 28.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Glenmark Pharmaceuticals had a promoter holding of 46.65% and a public holding of 53.36%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹8,900,000,000.00
₹10,400,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 May 1985 | Bank Of India | ₹890.00 Cr | Open |
| 29 Jul 2009 | Bank Of India | ₹60.00 Cr | Satisfied |
| 18 Jun 2009 | Axis Bank Limited | ₹75.00 Cr | Satisfied |
| 16 Jan 2009 | Central Bank Of India | ₹150.00 Cr | Satisfied |
| 09 Jun 2008 | Bank Of India | ₹170.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Glenmark Pharmaceuticals has a workforce of 13458 employees as of Mar 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Glenmark Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glenmark Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Glenmark Pharmaceuticals Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Patricia Susan Andrews was appointed as a Additional Director was appointed as a Additional Director on 14 Aug 2025 & has been associated with this company since 3 months 19 days . was completed.
Progress on Anurag Mantri was appointed as a Cfo was appointed as a Cfo on 06 Jun 2025 & has been associated with this company since 5 months 27 days . was documented.
The activity Anurag Mantri was appointed as a CFO was appointed as a CFO on 27 May 2025 & has been associated with this company since 6 months 7 days . was completed.
Progress on Glenmark Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Pradeep Kumar Sinha was appointed as a Director was appointed as a Director on 14 Feb 2025 & has been associated with this company since 9 months 17 days . was recorded as a recent event.
The CIN of Glenmark Pharmaceuticals Limited is L24299MH1977PLC019982.
Glenmark Pharmaceuticals Limited is headquartered at B-2Mahalaxmi Chambers22 Bhulabhai Desai Road Mahalaxmi, Mumbai, Maharashtra, 400026.
Glenmark Pharmaceuticals Limited was incorporated on 18 November 1977.
The current directors of Glenmark Pharmaceuticals Limited are
The primary industry of Glenmark Pharmaceuticals Limited is Manufacturing.
Glenmark Pharmaceuticals Limited is listed. It is listed on BSE: 532296 and NSE: GLENMARK.
The authorized capital of Glenmark Pharmaceuticals Limited is ₹277.00 Cr, and the paid-up capital is ₹28.22 Cr.
The compliance status of Glenmark Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX